Log in to save to my catalogue

Dexmedetomidine-midazolam versus Sufentanil-midazolam for Awake Fiberoptic Nasotracheal Intubation:...

Dexmedetomidine-midazolam versus Sufentanil-midazolam for Awake Fiberoptic Nasotracheal Intubation:...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_322e452a2f584e07a67c56e6638d8cb7

Dexmedetomidine-midazolam versus Sufentanil-midazolam for Awake Fiberoptic Nasotracheal Intubation: A Randomized Double-blind Study

About this item

Full title

Dexmedetomidine-midazolam versus Sufentanil-midazolam for Awake Fiberoptic Nasotracheal Intubation: A Randomized Double-blind Study

Publisher

China: Medknow Publications Pvt Ltd

Journal title

Chinese medical journal, 2015-12, Vol.128 (23), p.3143-3148

Language

English

Formats

Publication information

Publisher

China: Medknow Publications Pvt Ltd

More information

Scope and Contents

Contents

Background: Awake fiberoptic intubation (AFOI) is usually performed in the management of the predicted difficult airway. The aim of this study was to evaluate the feasibility of dexmedetomidine with midazolam (DM) and sufentanil with midazolam (SM) for sedation for awake fiberoptic nasotracheal intubation.
Methods: Fifty patients with limited mo...

Alternative Titles

Full title

Dexmedetomidine-midazolam versus Sufentanil-midazolam for Awake Fiberoptic Nasotracheal Intubation: A Randomized Double-blind Study

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_322e452a2f584e07a67c56e6638d8cb7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_322e452a2f584e07a67c56e6638d8cb7

Other Identifiers

ISSN

0366-6999

E-ISSN

2542-5641

DOI

10.4103/0366-6999.170260

How to access this item